Delivery Order SPE2DB20D3505-SPE2DB23FT5R1
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $10,517.27 delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract provides for the delivery of Linzess 145 MCG capsules to support military treatment facilities and other federal healthcare programs. The contract was awarded on a full and open competition basis without any set-aside designation....
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is valued at $1,127.46 and covers the delivery of LINZESS 145 MCG CAPSULE UU 30S, a medication for the treatment of gastrointestinal conditions. The award has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $10,048.22 for the supply of LINZESS 145 MCG CAPSULE UU 30S. The contract is a firm-fixed-price award with an ultimate completion date of March 14, 2024. The contracting agency is the Defense Logistics Agency (DLA), a defense agency. This award is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $1,387.98, is a delivery order contract for the pharmaceutical product LINZESS 145 MCG CAPSULE UU 30S. The contract has a period of performance through May 10, 2024 and uses a firm fixed price pricing type. No set-aside designation was used for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., involves the delivery of LINZESS 72 MCG CAPSULE UU 30S to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order. The contract has a ceiling value of $2,674.11 and a completion date of September 21, 2023. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $4,722.50 from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical care items. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,854.76 firm fixed-price delivery order is for the supply of LINZESS 145 MCG capsules. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $1,192.77 for the pharmaceutical product LINZESS 72 MCG CAPSULE UU 30S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 21, 2023. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order with a Firm Fixed Price valued at $2,409.42, covering the supply of LINZESS 290 MCG CAPSULE UU 30S. The contract has an ultimate completion date of October 27, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award is for medical supplies and pharmaceutical products provided by AmerisourceBergen Drug Corp to the Defense Logistics Agency (DLA). The $3,458.94 delivery order is for Linzess 290 MCG capsules and falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical division. This IDC, which runs through November 2026, enables the government to procure a wide range of pharmaceutical and medical commodities to...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB23FT5R1Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $4,483.03 for the pharmaceutical product LINZESS 290 MCG CAPSULE UU 30S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. Additionally, Amerisourcebergen maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These contracts demonstrate Amerisourcebergen's critical role as a key pharmaceutical distributor and healthcare solutions provider to various federal government agencies, ensuring the availability of essential medications, devices, and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 1/17/23 |